We are live on ! Find out more
VIGL

Vigil Neuroscience
VIGL

Delisted

VIGL was delisted on the 4th of August, 2025.

Back to rankings

2 hedge funds and large institutions have $4.55K invested in Vigil Neuroscience in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 76 closing their positions.

New
Increased
Maintained
Reduced
Closed

71.57% less ownership

Funds ownership: 71.63% → 0.06% (-72%)

97% less funds holding

Funds holding: 78 → 2 (-76)

100% less funds holding in top 10

Funds holding in top 10: 4 → 0 (-4)

100% less capital invested

Capital invested by funds: $266M → $4.55K (-$266M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 76

Holders
2
Holders Change
-76
Holders Change %
-97.44%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
76
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
XT
XTX Topco
Cayman Islands
+$119K

Top Sellers

Rank Fund Capital Flow
1
AVLSA
Atlas Venture Life Science Advisors
Massachusetts
-$46.4M
2
BCM
Beryl Capital Management
California
-$36.6M
3
GCL
Glazer Capital LLC
New York
-$23.9M
4
OBAM
ODDO BHF Asset Management
France
-$18.3M
5
6CM
683 Capital Management
New York
-$10M
Name Holding Trade Value Shares
Change 		Change in
Stake
NYLIM
51
New York Life Investment Management
New York
– -$422K -53,069 Closed
GCP
52
GSA Capital Partners
United Kingdom
– -$351K -44,179 Closed
SG Americas Securities
53
SG Americas Securities
New York
– -$346K -43,508 Closed
Goldman Sachs
54
Goldman Sachs
New York
– -$338K -42,562 Closed
Citadel Advisors
55
Citadel Advisors
Florida
– -$268K -33,766 Closed
IC
56
Ikarian Capital
Texas
– -$249K -31,360 Closed
FIA
57
FNY Investment Advisers
New York
– -$240K -30,235 Closed
DAM
58
Deltec Asset Management
New York
– -$239K -30,000 Closed
Marshall Wace
59
Marshall Wace
United Kingdom
– -$206K -25,900 Closed
GS
60
GTS Securities
New York
– -$199K -25,000 Closed
PAS
61
Point72 Asia (Singapore)
Singapore
– -$192K -24,132 Closed
American Century Companies
62
American Century Companies
Missouri
– -$182K -22,879 Closed
Charles Schwab
63
Charles Schwab
California
– -$164K -20,643 Closed
PAG
64
Private Advisor Group
New Jersey
– -$127K -16,000 Closed
CW
65
CreativeOne Wealth
Kansas
– -$107K -13,500 Closed
Morgan Stanley
66
Morgan Stanley
New York
– -$104K -13,091 Closed
VPIM
67
Vanguard Personalized Indexing Management
California
– -$89K -11,198 Closed
LIM
68
Longfellow Investment Management
Massachusetts
– -$73.5K -9,243 Closed
Citigroup
69
Citigroup
New York
– -$27.8K -3,500 Closed
Royal Bank of Canada
70
Royal Bank of Canada
Ontario, Canada
– -$10K -1,290 Closed
Bank of America
71
Bank of America
North Carolina
– -$9.43K -1,186 Closed
Wells Fargo
72
Wells Fargo
California
– -$4.89K -615 Closed
Raymond James Financial
73
Raymond James Financial
Florida
– -$3.98K -501 Closed
AUB
74
Atlantic Union Bankshares
Virginia
– -$1.79K -225 Closed
BNP Paribas Financial Markets
75
BNP Paribas Financial Markets
France
– -$1.19K -150 Closed
1 2
3
4

VIGL Hedge Fund Activity: Q3 2025 in Review

2 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Vigil Neuroscience (VIGL) for Q3 2025, worth a combined $4.55K — down 100% from $266M a quarter earlier.

Sellers outnumbered buyers: 76 funds closed out of VIGL and 0 opened new positions — a net loss of 76 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was XTX Topco, adding an estimated $119K. The largest seller was Atlas Venture Life Science Advisors, exiting entirely with an estimated $46.4M sold.

  • 2 institutional investors held Vigil Neuroscience (VIGL) as of Q3 2025, down from 78 in Q2 2025.
  • Funds reported $4.55K of Vigil Neuroscience stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Vigil Neuroscience positions in Q3 2025 and 76 closed out, a net change of -76 holders.
  • The largest Vigil Neuroscience buyer in Q3 2025 was XTX Topco, an estimated $119K added.
  • The largest Vigil Neuroscience seller in Q3 2025 was Atlas Venture Life Science Advisors, an estimated $46.4M sold.

Based on aggregated 13F filings for Q3 2025.